Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tetraploidy in BRCA2 breast tumours.
Jonsdottir AB, Stefansson OA, Bjornsson J, Jonasson JG, Ogmundsdottir HM, Eyfjord JE. Jonsdottir AB, et al. Among authors: eyfjord je. Eur J Cancer. 2012 Feb;48(3):305-10. doi: 10.1016/j.ejca.2011.11.008. Epub 2011 Nov 29. Eur J Cancer. 2012. PMID: 22133571
BRCA2 mutation carriers, reproductive factors and breast cancer risk.
Tryggvadottir L, Olafsdottir EJ, Gudlaugsdottir S, Thorlacius S, Jonasson JG, Tulinius H, Eyfjord JE. Tryggvadottir L, et al. Among authors: eyfjord je. Breast Cancer Res. 2003;5(5):R121-8. doi: 10.1186/bcr619. Epub 2003 Jun 24. Breast Cancer Res. 2003. PMID: 12927042 Free PMC article.
Aurora-A amplification associated with BRCA2 mutation in breast tumours.
Bodvarsdottir SK, Hilmarsdottir H, Birgisdottir V, Steinarsdottir M, Jonasson JG, Eyfjord JE. Bodvarsdottir SK, et al. Among authors: eyfjord je. Cancer Lett. 2007 Apr 8;248(1):96-102. doi: 10.1016/j.canlet.2006.06.003. Epub 2006 Jul 24. Cancer Lett. 2007. PMID: 16860930
BRCA2 heterozygosity delays cytokinesis in primary human fibroblasts.
Jonsdottir AB, Vreeswijk MP, Wolterbeek R, Devilee P, Tanke HJ, Eyfjörd JE, Szuhai K. Jonsdottir AB, et al. Among authors: eyfjord je. Cell Oncol. 2009;31(3):191-201. doi: 10.3233/CLO-2009-0465. Cell Oncol. 2009. PMID: 19478387 Free PMC article.
Tumour diploidy and survival in breast cancer patients with BRCA2 mutations.
Tryggvadottir L, Olafsdottir EJ, Olafsdottir GH, Sigurdsson H, Johannsson OT, Bjorgvinsson E, Alexiusdottir K, Stefansson OA, Agnarsson BA, Narod SA, Eyfjord JE, Jonasson JG. Tryggvadottir L, et al. Among authors: eyfjord je. Breast Cancer Res Treat. 2013 Jul;140(2):375-84. doi: 10.1007/s10549-013-2637-4. Epub 2013 Jul 16. Breast Cancer Res Treat. 2013. PMID: 23857704
Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers.
Jonasson JG, Stefansson OA, Johannsson OT, Sigurdsson H, Agnarsson BA, Olafsdottir GH, Alexiusdottir KK, Stefansdottir H, Munoz Mitev R, Olafsdottir K, Olafsdottir K, Arason A, Stefansdottir V, Olafsdottir EJ, Barkardottir RB, Eyfjord JE, Narod SA, Tryggvadóttir L. Jonasson JG, et al. Among authors: eyfjord je. Br J Cancer. 2016 Sep 27;115(7):776-83. doi: 10.1038/bjc.2016.249. Epub 2016 Aug 18. Br J Cancer. 2016. PMID: 27537391 Free PMC article.
151 results